More than 260,000 Penn Medicine patients have agreed to share their DNA for research via Penn Medicine BioBank

More than 260,000 people have signed up to participate in a project, called Penn Medicine BioBank, agreeing to have their DNA samples stored in secure freezers. By obtaining samples from a wide-cross section of humanity, researchers are able to cross-reference participants’ DNA with their health records and identify genetic variants for a range of diseases. 

Penn Medicine BioBank began over a decade ago and has doubled in size since the invitation to participate was incorporated into the electronic check-in process in 2020, which makes Penn’s one of the largest of a dozen similar efforts in the United States.

Unlike most other biobanks in the U.S. and abroad, Penn’s repository has a high percentage of samples from people of color, with nearly one-third from non-European ancestry. In the coming years, the total number of participants in Penn Medicine BioBank is expected to grow even more in the coming years. Read more here.

Skip to content